Scientific publications for BioPredictive non-invasive diagnostics

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

Callewaert N et al. · Nat Med · 2004 Match 100

We applied our 'clinical glycomics' technology, based on DNA sequencer/fragment analyzers…

FibroTest Alcohol Other

Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.

Sebagh M et al. · J Hepatol · 2012 Match 98

…Between 15 and 20 years, hepatic structural abnormalities were the only disorder…

ActiTest FibroTest Alcohol HBV +4

[Biomarkers for liver fibrosis: advances, advantages and disadvantages].

Cequera A et al. · Rev Gastroenterol Mex · 2014 Match 96

…molecular mechanisms that cause liver disorder and make it irreversible. One of…

FibroTest HCV

The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.

Simental-Mendía LE et al. · Ann Hepatol · 2016 Match 94

### Unlabelled Introduction and aim. Given that early identification of non-alcoholic fatty…

NashTest SteatoTest Metabolic

Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C.

Maor Y et al. · Haemophilia · 2010 Match 91

Non-invasive modalities to estimate fibrosis stage are desirable in hepatitis C…

FibroTest HCV

Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.

Laharie D et al. · J Hepatol · 2010 Match 89

…treatment of inflammatory disorders, its use is hampered by the risk of…

FibroTest Other

Liver fibrosis markers in alcoholic liver disease.

Chrostek L et al. · World J Gastroenterol · 2014 Match 87

…Therefore, the use of biomarkers may reduce the need for liver biopsy…

FibroTest Alcohol

Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.

Zelber-Sagi S et al. · Transl Res · 2015 Match 85

Retrospective studies suggest that coffee consumption may exert beneficial effects in patients…

FibroTest SteatoTest Metabolic

Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.

Jullian-Desayes I et al. · Respirology · 2016 Match 82

### Background And Objective Obstructive sleep apnoea (OSA) could be an independent risk…

NashTest SteatoTest Metabolic

Systematic review: Investigating the prognostic performance of four non-invasive tests in alcohol-related liver disease.

Rhodes FA et al. · J Gastroenterol Hepatol · 2021 Match 80

### Background And Aim Mortality of alcohol-related liver disease (ArLD) is increasing…

FibroTest Alcohol

An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.

Patel K et al. · J Viral Hepat · 2009 Match 78

Noninvasive markers that accurately follow changes in fibrosis may provide alternatives to…

FibroTest HCV

Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastography.

Knop V et al. · Nutrition · 2019 Match 75

### Objective Patients with short bowel syndrome (SBS) receiving long-term parenteral nutrition…

FibroTest SteatoTest Other

FibroMAX: towards a new universal biomarker of liver disease?

Morra R et al. · Expert Rev Mol Diagn · 2007 Match 73

Among the noninvasive alternatives to liver biopsy, several studies have demonstrated the…

ActiTest AshTest FibroTest NashTest +7

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.

Poynard T et al. · J Hepatol · 2013 Match 71

### Background & Aims Chronic hepatitis C is both a virologic and fibrotic disease…

FibroTest HCV

EASL clinical practical guidelines: management of alcoholic liver disease.

European Association for the Study of Liver · J Hepatol · 2012 Match 69

FibroTest Alcohol

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.

Ratziu V et al. · J Hepatol · 2011 Match 66

### Background & Aims Nonalcoholic steatohepatitis (NASH) is a prevalent liver disease associated with…

FibroTest Metabolic

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).

Poynard T et al. · BMC Gastroenterol · 2010 Match 64

…One challenge was to use them for estimating the prevalence of fibrosis…

FibroTest Alcohol HBV HCV +3

Biomarkers for liver disease in urea cycle disorders.

Nagamani SCS et al. · Mol Genet Metab · 2021 Match 62

### Background Urea cycle disorders (UCDs) are among the most common inborn errors…

ActiTest FibroTest Other

Noninvasive diagnosis in alcohol-related liver disease. Review

Hadefi A et al. · Health Sci Rep · 2020 Match 60

### Background Alcohol-related liver disease (ALD) represents a major cause of death…

FibroTest Alcohol

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.

European Association for the Study of the Liver (EASL) et al. · Obes Facts · 2016 Match 57

FibroTest SteatoTest Metabolic

An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Key publication

Myers RP et al. · Can J Gastroenterol · 2012 Match 55

Chronic hepatitis C remains a significant medical and economic burden in Canada…

FibroTest HCV

Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.

Stevenson M et al. · Health Technol Assess · 2012 Match 53

### Background Excessive alcohol consumption may lead to the development of alcohol-related…

FibroTest Alcohol